Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 35


Peritumoral Neuropilin-1 and VEGF receptor-2 expression increases time to recurrence in hepatocellular carcinoma patients undergoing curative hepatectomy.

Zhuang PY, Wang JD, Tang ZH, Zhou XP, Yang Y, Quan ZW, Liu YB, Shen J.

Oncotarget. 2014 Nov 30;5(22):11121-32.


ZBTB20 is involved in liver regeneration after partial hepatectomy in mouse.

Weng MZ, Zhuang PY, Hei ZY, Lin PY, Chen ZS, Liu YB, Quan ZW, Tang ZH.

Hepatobiliary Pancreat Dis Int. 2014 Feb;13(1):48-54.


[Comprehensive measures for improving the radical resection rate and safety of Bismuth-Corlette type III hilar cholangiocarcinoma].

Wang JD, Shen J, Zhou XP, Zhuang PY, Zhou D, Yang Y, Liu YB, Quan ZW.

Zhonghua Wai Ke Za Zhi. 2013 Jul;51(7):596-9. Chinese.


Novel sesquiterpenoid glycosides and sesquiterpenes from the roots of Illicium henryi.

Zhuang PY, Zhang GJ, Wang XJ, Zhang Y, Yu SS, Ma SG, Liu YB, Qu J, Li Y, Chen NH.

Planta Med. 2013 Oct;79(15):1453-60. doi: 10.1055/s-0033-1350769. Epub 2013 Aug 27.


Prognostic roles of cross-talk between peritumoral hepatocytes and stromal cells in hepatocellular carcinoma involving peritumoral VEGF-C, VEGFR-1 and VEGFR-3.

Zhuang PY, Shen J, Zhu XD, Lu L, Wang L, Tang ZY, Sun HC.

PLoS One. 2013 May 30;8(5):e64598. doi: 10.1371/journal.pone.0064598. Print 2013.


Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse models.

Zhu XD, Sun HC, Xu HX, Kong LQ, Chai ZT, Lu L, Zhang JB, Gao DM, Wang WQ, Zhang W, Zhuang PY, Wu WZ, Wang L, Tang ZY.

Angiogenesis. 2013 Oct;16(4):809-20. doi: 10.1007/s10456-013-9357-6. Epub 2013 May 29.


Direct transformation of lung microenvironment by interferon-α treatment counteracts growth of lung metastasis of hepatocellular carcinoma.

Zhuang PY, Shen J, Zhu XD, Zhang JB, Tang ZY, Qin LX, Sun HC.

PLoS One. 2013;8(3):e58913. doi: 10.1371/journal.pone.0058913. Epub 2013 Mar 18.


[Role of aerodynamic parameters in voice function assessment].

Guo YQ, Lin SZ, Xu XL, Zhou L, Zhuang PY, Jiang JJ.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012 Oct;47(10):858-60. Chinese.


Prenylated C6-C3 compounds from the roots of Illicium henryi.

Zhuang PY, Zhang GJ, Wang XJ, Zhang Y, Yu SS, Ma SG, Liu YB, Qu J, Li Y, Xu S, Lü HN, Chen X, Li L, Si YK, Zhang D.

Phytochemistry. 2013 Feb;86:176-83. doi: 10.1016/j.phytochem.2012.10.002. Epub 2012 Nov 8.


Xanthogranulomatous cholecystitis: a clinicopathological study of its association with gallbladder carcinoma.

Zhuang PY, Zhu MJ, Wang JD, Zhou XP, Quan ZW, Shen J.

J Dig Dis. 2013 Jan;14(1):45-50. doi: 10.1111/j.1751-2980.2012.00645.x.


Diagnostic and prognostic role of laparoscopic staging for gallbladder carcinoma.

Zhuang PY, Tang ZH, Liu YB, Quan ZW, Zhang YJ.

Dig Surg. 2012;29(5):367-73. doi: 10.1159/000343926. Epub 2012 Oct 26.


Up-regulation of platelet-derived growth factor-A is responsible for the failure of re-initiated interferon alpha treatment in hepatocellular carcinoma.

Zhang JB, Sun HC, Jia WD, Zhuang PY, Qian YB, Zhu XD, Kong LQ, Wang L, Wu WZ, Tang ZY.

BMC Cancer. 2012 Oct 1;12:439. doi: 10.1186/1471-2407-12-439.


Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.

Zhang W, Sun HC, Wang WQ, Zhang QB, Zhuang PY, Xiong YQ, Zhu XD, Xu HX, Kong LQ, Wu WZ, Wang L, Song TQ, Li Q, Tang ZY.

Gastroenterology. 2012 Dec;143(6):1641-1649.e5. doi: 10.1053/j.gastro.2012.08.032. Epub 2012 Aug 23.


Lycojaponicumins A-C, three alkaloids with an unprecedented skeleton from Lycopodium japonicum.

Wang XJ, Zhang GJ, Zhuang PY, Zhang Y, Yu SS, Bao XQ, Zhang D, Yuan YH, Chen NH, Ma SG, Qu J, Li Y.

Org Lett. 2012 May 18;14(10):2614-7. doi: 10.1021/ol3009478. Epub 2012 May 8.


Modification of chitosan membrane with poly(vinyl alcohol) and biocompatibility evaluation.

Zhuang PY, Li YL, Fan L, Lin J, Hu QL.

Int J Biol Macromol. 2012 Apr 1;50(3):658-63. doi: 10.1016/j.ijbiomac.2012.01.026. Epub 2012 Jan 24.


Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography.

Zhu XD, Zhang JB, Fan PL, Xiong YQ, Zhuang PY, Zhang W, Xu HX, Gao DM, Kong LQ, Wang L, Wu WZ, Tang ZY, Ding H, Sun HC.

BMC Cancer. 2011 Jan 20;11:28. doi: 10.1186/1471-2407-11-28.


[Somatostatin enhanced anti-tumor effect of doxorubicin on gallbladder cancer cells through the regulation of intracellular drug concentration].

Gong W, Qin YY, Li SG, Quan ZW, Li JY, Zhuang PY, Wan ZW.

Zhonghua Yi Xue Za Zhi. 2010 Oct 19;90(38):2718-22. Chinese.


Evaluation of two modified ECF regimens in the treatment of advanced gallbladder cancer.

Wang JD, Shi WB, Shen J, Zhuang PY, Quan ZW, Wang XF, Zhou XP, Li SG, Liu YB, Yang Y.

Med Oncol. 2011 Dec;28 Suppl 1:S295-300. doi: 10.1007/s12032-010-9758-y. Epub 2010 Dec 7.


Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects.

Zhang W, Zhu XD, Sun HC, Xiong YQ, Zhuang PY, Xu HX, Kong LQ, Wang L, Wu WZ, Tang ZY.

Clin Cancer Res. 2010 Jul 1;16(13):3420-30. doi: 10.1158/1078-0432.CCR-09-2904. Epub 2010 Jun 22.


High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resection.

Jia JB, Wang WQ, Sun HC, Zhu XD, Liu L, Zhuang PY, Zhang JB, Zhang W, Xu HX, Kong LQ, Lu L, Wu WZ, Wang L, Tang ZY.

Oncologist. 2010;15(7):732-43. doi: 10.1634/theoncologist.2009-0170. Epub 2010 Jun 15.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk